Company news
Aurisco Pharmaceutical Co. Ltd. news in 2026
Aurisco Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2026, newest first.
(605116)"Aurisco Pharmaceutical Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
October 8, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 28, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Wholly-owned Subsidiary
August 24, 2026
Announcement on the Wholly-owned Subsidiary Passing the U.S. FDA On-Site Inspection
August 12, 2026
Announcement on the Proposed Selection of the Company's Products in the 12th Batch of National Centralized Drug Procurement
August 3, 2026
Announcement on 2026 Interest Payment for "Aurisco Convertible Bonds"
July 20, 2026
Announcement on Inclusion of the Company's Main Products in the "National Essential Medicines List (2026 Edition)"
July 15, 2026
Announcement on Passing GMP Compliance Inspection for Drugs
July 13, 2026
Announcement on Conversion Result of Convertible Bonds and Share Changes
July 1, 2026
Correction Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
June 15, 2026
Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
June 12, 2026
Announcement on Not Revising Downward Conversion Price of ""Aurisco Convertible Bonds"
June 11, 2026
Announcement on Adjusting the Conversion Price of "Aurisco Convertible Bonds" Due to Implementation of Dividend Distribution
June 7, 2026
Indicative Announcement on ""Aurisco Convertible Bonds"" Expected to Meet Conditions for Revising Conversion Price
June 4, 2026
Indicative Announcement on Suspending Conversion of "Aurisco Convertible Bonds" When Implementing Dividend Distribution for 2025
June 1, 2026
Announcement on Obtaining Drug Registration Approval by the Company
May 11, 2026
Announcement on Resolutions of the 1st Meeting of the 4th Board of Directors
May 7, 2026
Report for Q1 2026
April 23, 2026
Announcement on the Estimated External Guarantee Limit
April 16, 2026
Announcement on Conversion Result of Convertible Bonds and Share Changes
April 1, 2026
Announcement on Results of Share Reduction by Director
March 31, 2026
Announcement on the Company Certified as High-tech Enterprise
March 20, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
March 17, 2026
Announcement on Shareholding Reduction Plan for Partial Board of Directors
January 30, 2026
Announcement on Implementation Result of Shares Repurchase and Share Changes
January 21, 2026
Announcement on Adjusting Upper Limit of Repurchase Price
January 12, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
January 4, 2026